Dynavax Technologies Corporation
(NASDAQ : DVAX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.52%196.991.2%$490.69m
GILDGilead Sciences, Inc.
-0.75%71.800.9%$442.91m
BIIBBiogen Inc.
0.37%316.711.3%$345.99m
ILMNIllumina, Inc.
-2.22%310.203.5%$333.80m
CELGCelgene Corporation
-0.98%79.821.2%$320.64m
VRTXVertex Pharmaceuticals Incorporated
-2.23%173.451.9%$231.00m
REGNRegeneron Pharmaceuticals, Inc.
-1.22%383.062.6%$221.24m
ALXNAlexion Pharmaceuticals, Inc.
-1.10%122.562.0%$215.73m
SRPTSarepta Therapeutics, Inc.
0.94%133.8016.4%$167.53m
AAgilent Technologies, Inc.
-3.17%62.241.5%$150.01m
BMRNBioMarin Pharmaceutical Inc.
-2.74%100.694.4%$135.55m
LGNDLigand Pharmaceuticals Incorporated
-1.89%181.3923.3%$115.97m
EXASExact Sciences Corporation
1.22%63.0125.3%$106.87m
ECYTEndocyte, Inc.
0.15%23.562.1%$96.01m
NBIXNeurocrine Biosciences, Inc.
-1.60%107.435.1%$94.17m

Company Profile

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.